StockWatch
·
HomeLiveWeekly

Strides Pharma Science Ltd

BSE: 532531

OverviewP/LShare Hold
values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-77.51184.97447.44709.92Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026

Margin Trend

percentage
OPM %NPM %
-18.10-4.299.5323.34Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026
PeriodQ4 FY2026Q3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025Q3 FY2025Q2 FY2025
INCOME
Revenue605.74+9.4%553.63+6.0%522.15+4.7%498.62-10.3%555.96+0.9%550.92-9.7%609.96
Other Income3.97-96.2%103.24+632.6%14.09+701.6%1.76-85.5%12.12+399.3%2.43-89.7%23.55
Total Income609.71-7.2%656.88+22.5%536.24+7.2%500.37-11.9%568.08+2.7%553.35-12.7%633.50
EXPENSES
Expenditure583.20+11.7%522.07+2.2%510.86+5.6%483.97-10.3%539.76+1.5%531.95-14.1%619.06
Tax10.15-21.3%12.91+294.0%-6.65-317.7%3.06-74.9%12.20+89.4%6.44+634.9%0.88
PROFIT
PBT26.51-80.3%134.80+431.0%25.39+54.8%16.40-42.1%28.32+32.5%21.38+48.1%14.43
Net Profit16.35-86.6%121.89+280.4%32.04+140.1%13.35-17.2%16.13+8.0%14.94-2.4%15.31
KEY METRICS
OPM %12.28%-2.39pp14.67%+2.75pp11.92%-1.56pp13.48%+1.26pp12.22%+18.79pp-6.57%+6.75pp-13.32%
NPM %2.68%-15.88pp18.56%+12.59pp5.97%+3.30pp2.67%-0.17pp2.84%+0.14pp2.70%+0.28pp2.42%
EPS1.77-86.6%13.22+279.9%3.48+140.0%1.45-17.1%1.75+8.0%1.62-2.4%1.66

Corporate Events

Board MeetingSTAR
2026
27Jun

Board Meeting

The Board of Directors of Strides Pharma Science Limited app…

BSE Filing ↗
DividendSTAR
2025
22Jul

₹4 / share

BSE Filing ↗
Board MeetingSTAR
2025
30Jan

Board Meeting

consider and approve the un-audited financial results (stand…

BSE Filing ↗
Stock SplitSTAR
2024
6Dec

1:2

BSE Filing ↗
Board MeetingSTAR
2024
24Oct

Board Meeting

Consider and approve the un-audited financial results (stand…

BSE Filing ↗
DividendSTAR
2024
9Sep

₹2.5 / share

BSE Filing ↗
Board MeetingSTAR
2024
29Jul

Board Meeting

Consider and approve Announcement of Board, consider and app…

BSE Filing ↗
DividendSTAR
2024
22May

₹2.5 / share

BSE Filing ↗
Board MeetingSTAR
2024
22May

Board Meeting

To consider and approve the audited financial results (stand…

BSE Filing ↗
Board MeetingSTAR
2023
30Oct

Board Meeting

Consider and approve un-audited financial results for the qu…

BSE Filing ↗
Board MeetingSTAR
2023
25Sep

Board Meeting

Consideration of proposal to combine CDMO interests

BSE Filing ↗